Bimodal action of the flavonoid quercetin on basophil function: An investigation of the putative biochemical targets

Clinical and Molecular Allergy

Volumn 8, Issue , 2010, Pages

  Chirumbolo, Salvatore ^a   Marzotto, Marta ^a   Conforti, Anita ^b,d   Vella, Antonio ^c   Ortolani, Riccardo ^c   Bellavite, Paolo ^a  

^a Institute of General Pathology   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CD123 ANTIGEN; CD63 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; QUERCETIN;

ADULT; AGED; ARTICLE; BASOPHIL; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GRANULOCYTE; HISTAMINE RELEASE; HUMAN; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 77957353300     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-8-13     Document Type: Article

References (53)

1. Hertog MG, Hollman PC. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996, 50:63-71.
2. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999, 37:937-942. 10.1016/S0278-6915(99)00079-4, 10541448.
3. Hollman PC, Katan MB. Health effects and bioavailability of dietary flavonols. Free Radic Res 1999, 31(Suppl):S75-S80. 10.1080/10715769900301351, 10694044.
4. Woodman OL, Chan EC. Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 2004, 31:786-790. 10.1111/j.1440-1681.2004.04072.x, 15566394.
5. Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, Ohkawara T, Hagihara K, Yamadori T, Shima Y, Ogata A, Kawase I, Tanaka T. Flavonoids and related compounds as anti-allergic substances. Allergol Int 2007, 56:113-123. 10.2332/allergolint.R-06-135, 17384531.
6. Jeong KW, Lee JY, Kang DI, Lee JU, Shin SY, Kim Y. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis. J Nat Prod 2009, 72:719-724. 10.1021/np800698d, 19236029.
7. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005, 26:343-356. 10.1016/j.ijantimicag.2005.09.002, 16323269.
8. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009, 58(9):537-52. 10.1007/s00011-009-0037-3, 19381780.
9. Terao J, Kawai Y, Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr 2008, 17(Suppl 1):291-293.
10. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009, 61:67-75.
11. Jayaraj R, Deb U, Bhaskar AS, Prasad GB, Rao PV. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environ Toxicol 2007, 22:472-479. 10.1002/tox.20283, 17696131.
12. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 2009, 89:905-912. 10.3945/ajcn.2008.26913, 2667658, 19158208.
13. Galluzzo P, Martini C, Bulzomi P, Leone S, Bolli A, Pallottini V, Marino M. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res 2009, 53:699-708. 10.1002/mnfr.200800239, 19194971.
14. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997, 27:31-40. 10.1080/01635589709514498, 8970179.
15. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008, 585:325-337. 10.1016/j.ejphar.2008.03.008, 18417116.
16. Bischoff SC. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008, 11:733-740. 10.1097/MCO.0b013e32831394b8, 18827577.
17. Middleton E, Drzewiecki G, Krishnarao D. Quercetin: an inhibitor of antigen-induced human basophil histamine release. J Immunol 1981, 127:546-550.
18. Middleton E, Krishnarao DG, Atkins D, Drzewiecki G. The flavonoids: a brief review and study of effects on antigen-induced histamine release from human basophils. Trans Am Clin Climatol Assoc 1981, 92:234-252. 2279505, 6169185.
19. Middleton E, Drzewiecki G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol 1984, 33:3333-3338. 10.1016/0006-2952(84)90102-3, 6208910.
20. Chirumbolo S, Conforti A, Ortolani R, Vella A, Marzotto M, Bellavite P. Stimulus-specific regulation of CD63 and CD203c membrane expression in human basophils by the flavonoid quercetin. Int Immunopharmacol 2010, 10:183-192. 10.1016/j.intimp.2009.10.014, 19887118.
21. Passante E, Ehrhardt C, Sheridan H, Frankish N. RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm Res 2009, 58:611-618. 10.1007/s00011-009-0028-4, 19301096.
22. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YH, Kim SH. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 2008, 31:1303-1311. 10.1007/s12272-001-2110-5, 18958421.
23. Shaik YB, Castellani ML, Perrella A, Conti F, Salini V, Tete S, Madhappan B, Vecchiet J, De Lutiis MA, Caraffa A, Cerulli G. Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents 2006, 20:47-52.
24. Calabrese EJ, Baldwin LA. Hormesis as a biological hypothesis. Environm Health Perspect 1998, 106:357-362.
25. Calabrese EJ. Hormesis: principles and applications for pharmacology and toxicology. Am J Pharmacol Toxicol 2008, 3:59-71.
26. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic Biol Med 2004, 36:838-849. 10.1016/j.freeradbiomed.2004.01.001, 15019969.
27. Dvorak AM. Ultrastructural studies of human basophils and mast cells. J Histochem Cytochem 2005, 53:1043-1070. 10.1369/jhc.5R6647.2005, 15923353.
28. Chirumbolo S, Vella A, Ortolani R, De Gironcoli M, Solero P, Tridente G, Bellavite P. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy 2008, 6:12. 10.1186/1476-7961-6-12, 2584049, 18925959.
29. Marone G, Poto S, Columbo M, Quattrin S, Condorelli M. Histamine release from human basophils in vitro: effects of age of cell donor. Monogr Allergy 1983, 18:139-143.
30. Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, Wilkinson M, Fletcher SR, Kratz A. Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol 2005, 11:62-70. 10.1532/LH96.04064, 15790554.
31. Middleton E, Drzewiecki G, Krishnarao D. Quercetin: an inhibitor of antigen-induced human basophil histamine release. J Immunol 1981, 127:546-550.
32. Middleton E. Effect of flavonoids on basophil histamine release and other secretory systems. Prog Clin Biol Res 1986, 213:493-506.
33. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008, 138:1615-1621.
34. Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol 2000, 279:R461-R467.
35. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998, 128:593-597.
36. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL. Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine. Mol Cell 2000, 6:909-919. 10.1016/S1097-2765(05)00089-4, 11090628.
37. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997, 53:1649-1657. 10.1016/S0006-2952(97)82453-7, 9264317.
38. Rommel C, Camps M, Ji H. PI3Kd and PI3Kg: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nature Rev Immunol 2007, 7:191-201.
39. Miura K, Macglashan DW. Expression of protein kinase C isozymes in human basophils: regulation by physiological and nonphysiological stimuli. Blood 1998, 92:1206-1218.
40. Warner JA, Macglashan DW. Protein kinase C (PKC) changes in human basophils. IgE-mediated activation is accompanied by an increase in total PKC activity. J Immunol 1989, 142:1669-1677.
41. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Doplhin AC. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nature Neuroscience 2004, 7:939-946. 10.1038/nn1300, 15311280.
42. Arcaro A, Wymann MP. Wortmannin is a potent phosphoinositide-3 kinase inhibitor: the role of phosphatidylinositol-3,4,5 triphosphate in neutrophil responses. Biochem J 1993, 296:297-301. 1137693, 8257416.
43. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K, Schultz G, Nurnberg B. Roles of Gbetagamma in membrane recruitment and activation of p110gamma/p101 phosphoinositide 3-kinase gamma. J Cell Biol 2003, 160:89-99. 10.1083/jcb.200210115, 2172741, 12507995.
44. Mocsai A, Jakus Z, Vantus T, Berton G, Lowell CA, Ligeti E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 2000, 164:4321-4331.
45. Hennersdorf F, Florian S, Jakob A, Baumgartner K, Sonneck K, Nordheim A, Biedermann T, Valent P, Buhring HJ. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of ige-dependent upregulation. Cell Res 2005, 15:325-335. 10.1038/sj.cr.7290301, 15916720.
46. Woo CS, Chan W, Sampson HA, Shreffler WG. Cell-by-cell characterization of signaling and activation marker upregulation during basophil stimulation and non specific desensitization. J All Clin Immunol 2009, 123. S199-post 764.
47. de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Bianca M, Demoly P, Ebo DG, Mayorga L, Monneret G, Sainte-Laudy J. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls: II Technical issues. J Invest Allergol Clin Immunol 2008, 18:143-155.
48. Bergstrand H, Lundquist B. Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. Allergy 2007, 47:353-361.
49. Nishino H, Naitoh E, Iwashima A, Umezawa K. Quercetin interacts with calmodulin, a calcium regulatory protein. Experientia 1984, 40:184-185. 10.1007/BF01963590, 6698173.
50. Dvorak AM. Ultrastructural studies of human basophils and mast cells. J Histochem Cytochem 2005, 53:1043-1070. 10.1369/jhc.5R6647.2005, 15923353.
51. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998, 20:237-248.
52. Graefe EU, Derendorf H, Veit M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharmacol Ther 1999, 37:219-233.
53. Erlund I, Freese R, Marniemi J, Hakala P, Alfthan G. Bioavailability of quercetin from berries and the diet. Nutr Cancer 2006, 54:13-17. 10.1207/s15327914nc5401_3, 16800769.